We also identified that an age-dependent transcription factor, C/EBPβ (CCAAT-enhancer binding protein β), controls δ-secretase expression in the brain, promoting AD pathology (Wang et al., 2018a). This evidence concerns the gene CEBPB and Alzheimer disease.